首页> 外文期刊>Genome Biology >The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesion
【24h】

The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesion

机译:从迁移性脑病灶活检中分离出的斯帕特氏菌tape虫Spirometra erinaceieuropaei的基因组

获取原文
获取外文期刊封面目录资料

摘要

Background: Sparganosis is an infection with a larval Diphyllobothriidea tapeworm. From a rare cerebral case presented at a clinic in the UK, DNA was recovered from a biopsy sample and used to determine the causative species as Spirometra erinaceieuropaei through sequencing of the cox1 gene. From the same DNA, we have produced a draft genome, the first of its kind for this species, and used it to perform a comparative genomics analysis and to investigate known and potential tapeworm drug targets in this tapeworm. Results: The 1.26 Gb draft genome of S. erinaceieuropaei is currently the largest reported for any flatworm. Through investigation of β-tubulin genes, we predict that S. erinaceieuropaei larvae are insensitive to the tapeworm drug albendazole. We find that many putative tapeworm drug targets are also present in S. erinaceieuropaei, allowing possible cross application of new drugs. In comparison to other sequenced tapeworm species we observe expansion of protease classes, and of Kuntiz-type protease inhibitors. Expanded gene families in this tapeworm also include those that are involved in processes that add post-translational diversity to the protein landscape, intracellular transport, transcriptional regulation and detoxification. Conclusions: The S. erinaceieuropaei genome begins to give us insight into an order of tapeworms previously uncharacterized at the genome-wide level. From a single clinical case we have begun to sketch a picture of the characteristics of these organisms. Finally, our work represents a significant technological achievement as we present a draft genome sequence of a rare tapeworm, and from a small amount of starting material.
机译:背景:孢子虫病是由幼虫Diphyllobothriidea worm虫感染。从英国一家诊所出现的罕见脑病例中,从活检样本中回收了DNA,并通过对cox1基因进行测序,将其确定为致病物种,如螺旋藻。我们用相同的DNA产生了一个基因组草图,这是该物种的第一个基因组,并用它来进行比较基因组分析,并研究该tape虫中已知的和潜在的tape虫药物靶标。结果:目前,对于所有扁虫,S。erinaceieuropaei的1.26 Gb草图基因组是最大的。通过对β-微管蛋白基因的研究,我们预测S. erinaceieuropaei幼虫对the虫药物阿苯达唑不敏感。我们发现许多推定的worm虫药物靶标也存在于erinaceieuropaei中,从而可能交叉应用新药。与其他测序的tape虫物种相比,我们观察到蛋白酶类别和Kuntiz型蛋白酶抑制剂的扩展。这种tape虫中扩展的基因家族还包括那些参与的过程,这些过程增加了蛋白质翻译后翻译多样性,细胞内转运,转录调控和排毒作用。结论:erinaceieuropaei基因组开始使我们了解以前在全基因组水平上未表征的tape虫的顺序。从一个临床案例中,我们已开始绘制这些生物特征的示意图。最后,我们的工作代表了一项重要的技术成就,因为我们提出了一种稀有tape虫的基因组序列草案,并使用了少量的起始原料。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号